TNM-021

N/A

Report date: 2023/01/07 20:44:14

Base Information

Drug NameTNM-021
Drug Alias NameTNM-021TNM021
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAdenovirus Infections, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZhuhai Trinomab Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai Trinomab Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAdenovirus Infections, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A